neoplasm
• mice show a decrease in incidence of metastases compared to double Trp53 and Nf1 heterozygotes, with 19.44% of mice with sarcomas showing metastases compared to 29.4% of double mutants
|
• mice show a decrease in incidence of sarcomas compared to double Trp53 and Nf1 heterozygotes, with 13.89% of mice developing soft tissue sarcomas compared to 59.5% of double mutants
• less proliferation is seen in tumors
|
immune system
• 25% of mice exhibit splenic hyperplasia
|
hematopoietic system
• 25% of mice exhibit splenic hyperplasia
|
growth/size/body
• 25% of mice exhibit splenic hyperplasia
|